Provider Guidance: Who Should Consider GLP-1 and When GLP-1 agonists may be appropriate for PCOS patients with concurrent obesity, prediabetes, or type 2 diabetes, where metabolic improvement could support hormonal balance
This can help you feel better and more energized
This means that whether you choose the arm, thigh, or abdomen, the tirzepatide is working to regulate your appetite and blood sugar
(2017) "Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial" The Lancet Diabetes & Endocrinology, 5(4) This article was reviewed by and approved by Alice Fletcher, Lead Bariatric Dietitian, on 3 April 2025
Epub 2023 Jun 5
UU., China e India estn sujetas a rigurosos procesos de evaluacin para garantizar el cumplimiento de la salud, la seguridad y el medio ambiente